Related Experiment Video
Updated: Aug 12, 2026

08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
[Sterility from hormonal causes and unexplained sterility. Treatment with cyclofenil. Double-blind controlled study]
Summary
Cyclofenil did not improve pregnancy rates for infertility patients compared to placebo over three cycles. The study highlights the significant role of the placebo effect and doctor-patient relationships in fertility treatments.
Area of Science:
- Reproductive Medicine
- Clinical Pharmacology
Background:
- Infertility affects a significant number of women, with causes including ovulatory deficiencies, cervical factors, and idiopathic origins.
- Effective pharmacological interventions for infertility are crucial for improving conception rates.
Purpose of the Study:
- To evaluate the efficacy of cyclofenil compared to placebo in achieving pregnancy in women with specific infertility causes.
- To assess the cumulative pregnancy rates over three treatment cycles.
Main Methods:
- A double-blind study involving 213 women with infertility.
- Participants were randomized to receive either cyclofenil or a placebo for three cycles.
- Pregnancy outcomes were monitored throughout the study period.
Main Results:
- The cumulative pregnancy rate was 22% in both the cyclofenil group (26/114) and the placebo group (21/99) after three cycles.
- No statistically significant difference in pregnancy rates was observed between cyclofenil and placebo treatments.
- This suggests a substantial placebo effect in the context of infertility treatment.
Conclusions:
- Cyclofenil demonstrated no superior efficacy over placebo in treating infertility over three cycles.
- The study underscores the importance of the doctor-patient relationship and the placebo effect in managing infertility.
- Further research may be needed to explore other therapeutic avenues or optimize existing treatments.
Related Concept Videos
Ovarian Cycle
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Infertility in Females
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...
Endometriosis, a condition characterized by abnormal growth of endometrial...

